JOHNSON & JOHNSON: Unit to Appeal ‘221 Patent Invalidity Ruling

Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).

The ‘221 patent claims combinations of acetaminophen…